Franklin Resources’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,769,944
Closed -$150M 1987
2020
Q3
$150M Sell
1,769,944
-675,642
-28% -$34.2M 0.07% 283
2020
Q2
$106M Buy
2,445,586
+651,500
+36% +$19M 0.05% 349
2020
Q1
$24.2M Buy
1,794,086
+87,300
+5% +$1.47M 0.02% 629
2019
Q4
$36.1M Buy
1,706,786
+800,000
+88% +$14.1M 0.02% 620
2019
Q3
$12M Hold
906,786
0.01% 850
2019
Q2
$12.6M Hold
906,786
0.01% 844
2019
Q1
$17.4M Buy
906,786
+130,900
+17% +$2.11M 0.01% 776
2018
Q4
$11.1M Hold
775,886
0.01% 851
2018
Q3
$16.2M Hold
775,886
0.01% 834
2018
Q2
$18.4M Buy
775,886
+86
+0% +$1.73K 0.01% 795
2018
Q1
$11.3M Hold
775,800
0.01% 903
2017
Q4
$12.5M Buy
+775,800
New +$9.16M 0.01% 896

Franklin Resources's IMMU Position: Q4 2020 in Review

Franklin Resources sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,769,944 shares — an estimated $150M sold.

Franklin Resources first reported a position in IMMU in Q4 2017 and held it in 12 quarters. The position peaked at $150M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Franklin Resources reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Franklin Resources sold 1,769,944 Immunomedics Inc shares in Q4 2020, an estimated $150M.
  • Franklin Resources first reported a position in Immunomedics Inc in Q4 2017 and held it in 12 quarters.
  • Franklin Resources's Immunomedics Inc position peaked at $150M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Franklin Resources's 13F filing for Q4 2020, filed 10 Feb 2021.